News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Biopharma Inc. (CBPC.OB) Reports Progress on Topical Antiviral


10/19/2007 6:07:14 AM

China Biopharma said that its partner, Soonfast Pharmaceutical, completed a trial production run of its topical antiviral. In June, China Biopharma acquired the ex-China rights to the product, which treats herpes simplex virus (HSV) and human papillomavirus (HPV). The product has been approved for use in China, and will launch in November, now that commercial-level manufacturing has begun.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES